These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15604847)

  • 1. From balloon angioplasty to drug-eluting stents: revolution or evolution?
    King SB
    Am Heart Hosp J; 2004; 2(2):73-9. PubMed ID: 15604847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug-eluting stents: do they keep their promises?].
    Nordmann A
    Praxis (Bern 1994); 2006 Apr; 95(15):581-3. PubMed ID: 16640178
    [No Abstract]   [Full Text] [Related]  

  • 3. Perspectives of drug-eluting stents: the next revolution.
    Moses JW; Kipshidze N; Leon MB
    Am J Cardiovasc Drugs; 2002; 2(3):163-72. PubMed ID: 14727979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In-stent restenosis: which indications for drug-eluting stent?].
    Eltchaninoff H; Tron C; Cribier A
    Ann Cardiol Angeiol (Paris); 2003 Jun; 52(3):198-9. PubMed ID: 12938576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus-eluting stents: a review of experimental and clinical findings.
    Toutouzas K; Di Mario C; Falotico R; Takagi T; Stankovic G; Albiero R; Corvaja N; Colombo A
    Z Kardiol; 2002; 91 Suppl 3():49-57. PubMed ID: 12641015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-eluting stents in complex lesions].
    Lefèvre T
    Ann Cardiol Angeiol (Paris); 2003 Jun; 52(3):176-83. PubMed ID: 12938571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents.
    Pan M; Suárez de Lezo J; Medina A; Romero M; Delgado A; Segura J; Ojeda S; Mazuelos F; Hernandez E; Melian F; Pavlovic D; Esteban F; Herrador J
    Am Heart J; 2007 Jan; 153(1):15.e1-7. PubMed ID: 17174630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
    Dibra A; Kastrati A; Mehilli J; Pache J; Schühlen H; von Beckerath N; Ulm K; Wessely R; Dirschinger J; Schömig A;
    N Engl J Med; 2005 Aug; 353(7):663-70. PubMed ID: 16105990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
    Stone GW; Moses JW; Ellis SG; Schofer J; Dawkins KD; Morice MC; Colombo A; Schampaert E; Grube E; Kirtane AJ; Cutlip DE; Fahy M; Pocock SJ; Mehran R; Leon MB
    N Engl J Med; 2007 Mar; 356(10):998-1008. PubMed ID: 17296824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stents in interventional cardiology].
    Grinius V; Navickas R; Unikas R
    Medicina (Kaunas); 2007; 43(3):183-9. PubMed ID: 17413246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
    Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
    JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [When are drug-eluting stents effective? A critical analysis of the presently available data].
    Silber S
    Z Kardiol; 2004 Sep; 93(9):649-63. PubMed ID: 15365732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
    Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
    JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug eluting stents: initial experiences.
    Grube E; Gerckens U; Müller R; Büllesfeld L
    Z Kardiol; 2002; 91 Suppl 3():44-8. PubMed ID: 12641014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
    Windecker S; Remondino A; Eberli FR; Jüni P; Räber L; Wenaweser P; Togni M; Billinger M; Tüller D; Seiler C; Roffi M; Corti R; Sütsch G; Maier W; Lüscher T; Hess OM; Egger M; Meier B
    N Engl J Med; 2005 Aug; 353(7):653-62. PubMed ID: 16105989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stents.
    Whitlow P
    J Invasive Cardiol; 2004 Jul; 16(7 Suppl):2S-6S. PubMed ID: 23573564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of various percutaneous interventions for in-stent restenosis: comprehensive network meta-analysis of randomized controlled trials.
    Sethi A; Malhotra G; Singh S; Singh PP; Khosla S
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002778. PubMed ID: 26546577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stents: from randomized trials to the real world.
    Saia F; Degertekin M; Lemos PA; Serruys PW
    Minerva Cardioangiol; 2004 Oct; 52(5):349-63. PubMed ID: 15514571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents.
    Babapulle MN; Joseph L; Bélisle P; Brophy JM; Eisenberg MJ
    Lancet; 2004 Aug 14-20; 364(9434):583-91. PubMed ID: 15313358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stent: the emerging technique for the prevention of restenosis.
    Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
    Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.